The Technical Analyst
Select Language :

Dermata Therapeutics, [DRMA]

Exchange: Sector: Healthcare Industry: Biotechnology

Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

Dermata Therapeutics, is listed at the NASDAQ Exchange

-3.91% $2.70

Last updated: 28 Nov 2021 @ 17:51 pm


FUNDAMENTALS
MarketCap: 22.49 mill
EPS: -3.09
P/E: 0.000
Earnings Date: N/A
SharesOutstanding: 8.33 mill
Avg Daily Volume: 0.446 mill
QUARTER GROWTHS
2/21
Revenuen/a
Gr.Profitn/a
Ebit
Asset n/a
Debtn/a
PE RATIO: COMPANY / SECTOR
nanx
Company: PE 0.000 | sector: PE nan
PE RATIO: COMPANY / INDUSTRY
nanx
Company: PE 0.000 | industry: PE nan

Insider Trading

Date Person Action Amount type
2021-11-23 Proehl Gerald T Buy 20 000 Common Stock
2021-09-01 Van Hoose Kyri K. Buy 75 000 Stock Option (right to Buy)
2021-08-17 Proehl Investment Ventures Llc Buy 27 987 Warrant to Purchase Common Stock
2021-08-17 Proehl Investment Ventures Llc Buy 573 750 Series 1a Warrants
2021-08-17 Proehl Investment Ventures Llc Buy 573 750 Series 1a Warrants
INSIDER POWER
94.05
Last 63 transactions
Buy: 9 380 653 | Sell: 256 469

Forecast: 14:40 - $2.78

Live Trading Signals (every 1 min)

Forecast 1: 13:10 - $2.75
Forecast 2: 14:00 - $2.78
Forecast 3: 14:40 - $2.78
SCORE
-0.58
Hold
Score Algorithm Version: 0.9M
Last version updated: Thurs 28th Oct 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.70 (-3.91% )
Volume 0.124 mill
Avg. Vol. 0.446 mill
% of Avg. Vol 27.84 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Dermata Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Dermata Therapeutics, Inc.

RSI

Intraday RSI14 chart for Dermata Therapeutics, Inc.
The Live Chart for Dermata Therapeutics, Inc.
Profile picture for
            Dermata Therapeutics, Inc.

DRMA

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. It is also developing DMT410 for the treatment of hyperhidrosis and aesthetic conditions. The company was founded in 2014 and is headquartered in San Diego, California.

Last 10 Buy Signals
Date Signal @
BTCUSDNov 28 - 12:3054 098
XRPUSDNov 28 - 12:260.920
XRPUSDNov 28 - 12:230.921
XRPUSDNov 28 - 12:190.922
BTCUSDNov 28 - 12:1654 220
XRPUSDNov 28 - 12:130.923
BTCUSDNov 28 - 12:1054 267
BTCUSDNov 28 - 12:0454 208
BTCUSDNov 28 - 12:0054 239
XRPUSDNov 28 - 12:000.921

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.